Editorial: treating hepatorenal syndrome-a window and the views. Authors' reply

Affiliations

¹ Division of Nephrology, Department of Medicine, Massachusetts General Hospital, Boston, MA, USA.
² Mallinckrodt Pharmaceuticals, Bedminster, NJ, USA.
³ UCL Institute of Liver and Digestive Health, Royal Free Hospital, University College London, London, UK.

Editorial

Andrew S Allegretti et al. Aliment Pharmacol Ther. 2020 Sep.

. 2020 Sep;52(5):897.

doi: 10.1111/apt.15981.

¹ Division of Nephrology, Department of Medicine, Massachusetts General Hospital, Boston, MA, USA.
² Mallinckrodt Pharmaceuticals, Bedminster, NJ, USA.
³ UCL Institute of Liver and Digestive Health, Royal Free Hospital, University College London, London, UK.

No abstract available

Comment on

Real-world treatment patterns and outcomes using terlipressin in 203 patients with the hepatorenal syndrome.
Moore K, Jamil K, Verleger K, Luo L, Kebede N, Heisen M, Corman S, Leonardi R, Bakker R, Maï C, Shamseddine N, Huang X, Allegretti AS. Moore K, et al. Aliment Pharmacol Ther. 2020 Jul;52(2):351-358. doi: 10.1111/apt.15836. Epub 2020 Jun 4. Aliment Pharmacol Ther. 2020. PMID: 32495956 Free PMC article.
Editorial: treating hepatorenal syndrome-a window and the views.
Palaniyappan N, Aithal GP. Palaniyappan N, et al. Aliment Pharmacol Ther. 2020 Sep;52(5):895-896. doi: 10.1111/apt.15943. Aliment Pharmacol Ther. 2020. PMID: 32852817 No abstract available.

1. Palaniyappan N, Aithal GP. Editorial: treating hepatorenal syndrome - a window and the views. Aliment Pharmacol Ther. 2020;52:895-896.
1. Moore K, Jamil K, Verleger K, et al. Real-world treatment patterns and outcomes using terlipressin in 203 patients with the hepatorenal syndrome. Aliment Pharmacol Ther. 2020;52:351-358.
1. European Association for the Study of the Liver. EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis. J Hepatol. 2018;69:406-460.
1. Angeli P, Ginès P, Wong F, et al. Diagnosis and management of acute kidney injury in patients with cirrhosis: revised consensus recommendations of the International Club of Ascites. J Hepatol. 2015;62:968-974.
1. Cavallin M, Kamath PS, Merli M, et al. Terlipressin plus albumin versus midodrine and octreotide plus albumin in the treatment of hepatorenal syndrome: a randomized trial. Hepatology. 2015;62:567-574.